How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

GlaxoSmithKline is looking for opportunities in Infectious diseases

Organization name

GlaxoSmithKline

Profile

Collaboration with others in industry, academia, government and non-governmental organisations and healthcare in general is fundamental to GSK's strategic priorities of growing a diversified, global business and delivering more products of value.

Their Worldwide Business Development group is a global team of scientific, transaction, and alliance management experts building diverse collaborations relating to compounds (early stage discovery programs through to marketed products) and technologies. If you prefer to retain the independence to develop alliance compounds through to proof of concept, their Options based collaborative model offers you the flexibility for you to do so. They have an industry leading record in establishing and maintaining collaborations with scientists and organizations in both industry and academia and are experts at building progressive relationships that are strong and mutually beneficial.

Priority areas of science

They are strongly committed to research collaborations with academic groups to advance scientific understanding relevant to their key areas of focus:

  • Respiratory
  • Metabolic pathways
  • Immuno-inflammation
  • Neurosciences
  • Infectious diseases
  • Ophthalmology
  • Oncology
  • Biopharmaceuticals

Specific topics of interest currently for academic collaboration are outlined below.

Infectious diseases

  • New approaches for treating viral (including HCV, HIV, RSV, HPV, HBV) and bacterial infections
  • Rapid diagnostic systems for viral and bacterial infections
  • Generation of epidemiology/surveillance data, particularly in emerging markets
  • Validated biomarkers and surrogates for cardiovascular risk factors in HIV showing links between changes in biomarkers/surrogates and clinical events
  • Validated cardiovascular risk calculator for HIV patients
  • Enhanced quality and more efficient short-term surrogate endpoints for long-term clinical events in HIV and HCV
  • Validated quality of life tools for HIV

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries